Market revenue in 2022 | USD 170.4 million |
Market revenue in 2030 | USD 366.9 million |
Growth rate | 10.1% (CAGR from 2022 to 2030) |
Largest segment | 13-24 weeks |
Fastest growing segment | 0-12 weeks |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | 0-12 weeks, 13-24 weeks, 25-36 weeks |
Key market players worldwide | CooperSurgical, Natera Inc, Eurofins Scientific SE, Illumina Inc, Centogene NV Ordinary Shares, MedGenome, Myriad Genetics Inc, Roche Holding AG, Qiagen NV, Labcorp Holdings Inc, Quest Diagnostics Inc, Biora Therapeutics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non invasive prenatal testing market will help companies and investors design strategic landscapes.
13-24 weeks was the largest segment with a revenue share of 52.11% in 2022. Horizon Databook has segmented the Latin America non invasive prenatal testing market based on 0-12 weeks, 13-24 weeks, 25-36 weeks covering the revenue growth of each sub-segment from 2018 to 2030.
Technological developments are expected to contribute to market expansion. Increasing government expenditure on R&D, presence of skilled healthcare professionals, rising focus of multinational pharmaceutical companies in the clinical diagnostics sector, and the increase in patient awareness levels are expected to drive the market growth over the forecast period.
Rising incidence of chronic diseases coupled with growing geriatric population is also a factor driving the regional clinical diagnostic market. Furthermore, increasing healthcare spending in developing countries in this region and increasing medical tourism are responsible for market growth.
The Human Genome & Stem Cell Research Center (HUG - CELL) is a notable body at the University of São Paulo, which researches human genome and sequence mapping of indigenous populations and crops of Brazil.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America non invasive prenatal testing market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America non invasive prenatal testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account